Travere Therapeutics, Inc.TVTXNASDAQ
LOADING
|||
PB Ratio: Premium Valuation
Trending higher, above historical average, strong compound growth.
Left:
||||
Price-to-book ratio
Latest
23.26
↑ 180% above average
Average (9y)
8.30
Historical baseline
Range
High:31.29
Low:2.16
CAGR
+30.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | 23.26 | +599.6% |
| 2023 | 3.32 | -89.4% |
| 2022 | 31.29 | +409.0% |
| 2021 | 6.15 | +0.2% |
| 2020 | 6.13 | +125.7% |
| 2019 | 2.72 | -5.4% |
| 2018 | 2.87 | +3.1% |
| 2017 | 2.79 | +22.5% |
| 2016 | 2.28 | +5.4% |
| 2015 | 2.16 | - |